234 related articles for article (PubMed ID: 15282675)
1. Desferrioxamine related maculopathy: a case report.
Arora A; Wren S; Gregory Evans K
Am J Hematol; 2004 Aug; 76(4):386-8. PubMed ID: 15282675
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and therapeutic challenges.
Reddy S; Slakter J; Aaberg TM; Singh RP; Kaiser PK
Retina; 2007 Jun; 27(5):642-7. PubMed ID: 17558329
[No Abstract] [Full Text] [Related]
3. Deferoxamine-related ocular toxicity: incidence and outcome in a pediatric population.
Baath JS; Lam WC; Kirby M; Chun A
Retina; 2008 Jun; 28(6):894-9. PubMed ID: 18536609
[TBL] [Abstract][Full Text] [Related]
4. [Bull's-Eye Maculopathy with Deferoxamine Treatment].
Schmidt D; Finke J
Klin Monbl Augenheilkd; 2004 Mar; 221(3):204-9. PubMed ID: 15052528
[TBL] [Abstract][Full Text] [Related]
5. Retinal abnormalities in β-thalassemia major.
Bhoiwala DL; Dunaief JL
Surv Ophthalmol; 2016; 61(1):33-50. PubMed ID: 26325202
[TBL] [Abstract][Full Text] [Related]
6. [Ocular toxicity of deferoxamine: description and analysis of three observations].
Szwarcberg J; Mack G; Flament J
J Fr Ophtalmol; 2002 Jun; 25(6):609-14. PubMed ID: 12223949
[TBL] [Abstract][Full Text] [Related]
7. [Retinal pigment epithelium--desferal].
Roulez F
Bull Soc Belge Ophtalmol; 2007; (304):59-66. PubMed ID: 17718228
[TBL] [Abstract][Full Text] [Related]
8. Macular degeneration in a patient with aceruloplasminemia, a disease associated with retinal iron overload.
Dunaief JL; Richa C; Franks EP; Schultze RL; Aleman TS; Schenck JF; Zimmerman EA; Brooks DG
Ophthalmology; 2005 Jun; 112(6):1062-5. PubMed ID: 15882908
[TBL] [Abstract][Full Text] [Related]
9. [Poisoning of retinal pigment epithelium by deferoxamine. A case report].
Charton N; Sahel JA; Flament J
Bull Soc Ophtalmol Fr; 1990; 90(6-7):599-602. PubMed ID: 2225255
[TBL] [Abstract][Full Text] [Related]
10. [Ocular side effects of deferoxamine therapy in aplastic anemia with transfusion-induced hemochromatosis].
Spraul CW; Schicketanz C; Lang GE
Klin Monbl Augenheilkd; 1996 Jul; 209(1):31-6. PubMed ID: 8965474
[TBL] [Abstract][Full Text] [Related]
11. Geographic atrophy of the retinal pigment epithelium: diagnosis and vision rehabilitation.
Potter JW; Thallemer JM
J Am Optom Assoc; 1981 Jun; 52(6):503-8. PubMed ID: 7264141
[TBL] [Abstract][Full Text] [Related]
12. Desferrioxamine-related ocular toxicity: a case report.
Simon S; Athanasiov PA; Jain R; Raymond G; Gilhotra JS
Indian J Ophthalmol; 2012 Jul; 60(4):315-7. PubMed ID: 22824603
[TBL] [Abstract][Full Text] [Related]
13. [Acute macular neuroretinopathy--case report].
Pojda-Wilczek D; Herba E
Klin Oczna; 2005; 107(1-3):127-9. PubMed ID: 16052823
[TBL] [Abstract][Full Text] [Related]
14. EOG as a monitor of desferrioxamine retinal toxicity.
Hidajat RR; McLay JL; Goode DH; Spearing RL
Doc Ophthalmol; 2004 Nov; 109(3):273-8. PubMed ID: 15957612
[TBL] [Abstract][Full Text] [Related]
15. [Macular pigmentary epiteliopathy].
Macarie S; Călugăru D; Kaucsar E; Olaru G
Oftalmologia; 2006; 50(2):32-5. PubMed ID: 16927755
[TBL] [Abstract][Full Text] [Related]
16. Recent acquisitions in the management of iron overload.
Franchini M
Ann Hematol; 2005 Oct; 84(10):640-5. PubMed ID: 16025271
[TBL] [Abstract][Full Text] [Related]
17. [Acute macular neuroretinopathy: a case report].
Carrasco B; Calonge M; Rodríguez De La Rúa E; Aragón JA; Pastor JC
Arch Soc Esp Oftalmol; 2001 May; 76(5):319-22. PubMed ID: 11373709
[TBL] [Abstract][Full Text] [Related]
18. [Macula in glaucoma patients].
Stefan C; Neacsu A; Poştaliu D
Oftalmologia; 2004; 48(3):49-51. PubMed ID: 15598051
[TBL] [Abstract][Full Text] [Related]
19. Bilateral vitelliform maculopathy and deferoxamine toxicity.
Gonzales CR; Lin AP; Engstrom RE; Kreiger AE
Retina; 2004 Jun; 24(3):464-7. PubMed ID: 15187676
[No Abstract] [Full Text] [Related]
20. Delayed onset chloroquine retinopathy: case report.
Martin LJ; Bergen RL; Dobrow HR
Ann Ophthalmol; 1978 Jun; 10(6):723-6. PubMed ID: 677653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
